Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research focused on Pituitary tumors and Neuroendocrine tumors, with related work in Temozolomide, Radiation therapy, Corticotropic cell. Notable publications include 'A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal', 'European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas', and 'A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up'.
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
Aggressive pituitary tumours and pituitary carcinomas
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution
Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Aggressive pituitary tumours and carcinomas: two sides of the same coin?
Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
MicroRNAs in pituitary tumors
Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
Somatic<i>GPR101</i>Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management
Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature
Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors
Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth
Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors
Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort
MANAGEMENT OF ENDOCRINE DISEASE: Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
miR-23b and miR-130b expression is downregulated in pituitary adenomas
A Prognostic Clinicopathologic Classification of Pituitary Endocrine Tumors
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up